We are live on ! Find out more
1CM

1492 Capital Management Portfolio holdings

AUM $263M
1-Year Est. Return 61.9%
This Fund
S&P 500
This Quarter Est. Return
+8.87%
1 Year Est. Return
+61.9%
3 Year Est. Return
+187.15%
5 Year Est. Return
+242.53%
10 Year Est. Return
+2,731.07%
AUM
$172M
AUM Growth
+$12.7M
Cap. Flow
+$4.52M
Cap. Flow %
2.62%
Top 10 Hldgs %
32.71%
Holding
165
New
41
Increased
29
Reduced
42
Closed
31

Sector Composition

Rank Sector Weight
1 Technology 19.09%
2 Healthcare 16.04%
3 Consumer Discretionary 13.67%
4 Industrials 12.24%
5 Financials 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HF
151
DELISTED
HFF Inc.
HF
-113,759
Closed -$4.09M
P
152
DELISTED
Pandora Media Inc
P
-54,392
Closed -$970K
APOL
153
DELISTED
Apollo Education Group Inc Class A
APOL
-27,778
Closed -$948K
MFLX
154
DELISTED
MULTI-FINELINE ELECTRONIX INC
MFLX
-21,079
Closed -$237K
SLXP
155
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
-62,397
Closed -$7.17M
SABA
156
DELISTED
SABA SOFTWARE INC
SABA
-451,014
Closed -$3.68M
NMRX
157
DELISTED
Numerex Corp
NMRX
-10,417
Closed -$115K
ETRM
158
DELISTED
EnteroMedics Inc.
ETRM
-170
Closed -$254K

Similar funds

1492 Capital Management's Q1 2015 Portfolio in Review

As of Q1 2015, 1492 Capital Management held 165 positions worth $172M, up 8% from $160M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

1492 Capital Management's Q1 2015 filing shows 41 new, 29 increased, 42 reduced and 31 closed positions. Its largest new stake was Radware: 239,040 shares worth $5M. The largest sale was SALIX PHARMACEUTICALS LTD DEL, an estimated $7.17M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • 1492 Capital Management's largest Q1 2015 buy was Radware: 239,040 shares worth $5M.
  • 1492 Capital Management added most to Axon Enterprise in Q1 2015, an estimated $2.93M increase.
  • 1492 Capital Management's biggest Q1 2015 reduction was STAAR Surgical, cutting an estimated $1.95M.
  • 1492 Capital Management fully exited SALIX PHARMACEUTICALS LTD DEL in Q1 2015, selling an estimated $7.17M.
  • 1492 Capital Management's ten largest holdings make up 33% of its $172M portfolio in Q1 2015.
  • 1492 Capital Management opened 41 new positions and closed 31 in Q1 2015.
  • 1492 Capital Management's portfolio value rose 8% quarter-over-quarter to $172M.

Based on 1492 Capital Management's 13F filing for Q1 2015, filed 13 May 2015.